A carregar...
Comparison of second-line therapy in IVIg-refractory Kawasaki disease: a systematic review
BACKGROUND: Evidence remains contradictory regarding second-line therapy in patients with Kawasaki disease (KD) refractory to initial intravenous immunoglobulin (IVIg). The objective of this study aims to evaluate the efficacy and safety of three treatments [i.e. a second IVIg infusion, methylpredni...
Na minha lista:
| Publicado no: | Pediatr Rheumatol Online J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6882052/ https://ncbi.nlm.nih.gov/pubmed/31775898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12969-019-0380-z |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|